Skip to main content
Equibles

BANK OF MONTREAL /CAN/

Bank

Position in PFE — Pfizer Inc

CIK 927971 TORONTO, A6
Back to PFE Full portfolio

Position in PFE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$196,688,325
-$18,612,404 QoQ
Shares Held
8,168,120
+6.5% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#66
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2026
CallValue
$4,334,400
CallShares
180,000
PutValue
$4,334,400
PutShares
180,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. PFE ranks #9 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 1,724,702 $2,068,659,488
2 JNJ
Johnson & Johnson
 4,646,972 $1,180,191,474
3 ABBV
AbbVie Inc.
 3,470,007 $873,192,557
4 MRK
Merck & Co., Inc.
 5,565,728 $715,196,045
5 GILD
Gilead Sciences, Inc.
 3,772,428 $476,608,548
6 AZN
Astrazeneca PLC
 2,359,807 $447,466,599
7 AMGN
Amgen Inc
 882,230 $319,473,122
8 GSK
GSK plc
 4,042,863 $211,926,875

All Filings in PFE

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,334,400 180,000
2026-06-30 $4,334,400 180,000
2026-06-30 $196,688,325 8,168,120
2026-03-31 $215,300,729 7,667,405
2026-03-31 $1,993,680 71,000
2026-03-31 $1,993,680 71,000
2025-12-31 $240,100,214 9,642,579
2025-12-31 $423,300 17,000
2025-12-31 $423,300 17,000
2025-09-30 $4,721,444 185,300
2025-09-30 $235,498,002 9,242,465
2025-06-30 $208,611,083 8,606,068
2025-03-31 $248,137,815 9,792,337
2024-12-31 $285,509,993 10,761,779
2024-09-30 $444,727,748 15,367,234
2024-09-30 $882,670 30,500
2024-06-30 $421,930,618 15,079,722
2024-06-30 $853,390 30,500
2024-03-31 $412,238,732 14,855,450
2024-03-31 $846,375 30,500
2023-12-31 $1,741,795 60,500
2023-12-31 $385,020,038 13,373,395
2023-09-30 $9,304,185 280,500
2023-09-30 $558,827,392 16,847,374
2023-06-30 $10,288,740 280,500
2023-06-30 $528,746,599 14,415,120
2023-03-31 $11,444,400 280,500
2023-03-31 $486,628,206 11,927,162
2022-12-31 $689,212,327 13,450,670
2022-09-30 $526,551,693 12,032,717
2022-06-30 $10,486 200
2022-06-30 $662,082,103 12,627,925
2022-03-31 $12,942,500 250,000
2022-03-31 $737,220,377 14,240,301
2021-12-31 $790,209,873 13,382,047
2021-12-31 $8,857,500 150,000
2021-09-30 $17,225,505 400,500
2021-09-30 $759,779,645 17,665,186
2021-06-30 $478,312,766 12,214,320
2021-03-31 $385,311,153 10,635,141
2020-12-31 $393,044,070 10,677,644
2020-12-31 $3,890,817 105,700
2020-12-31 $217,179 5,900
2020-09-30 $345,190,863 9,405,755
2020-09-30 $216,529 5,900
2020-06-30 $7,082,827 216,600
2020-06-30 $335,937,808 10,273,317
2020-03-31 $352,245,371 10,791,846

Report a Problem

Category
Description
Email (optional, for follow-up)